Genetic Signatures signs up

By Staff Writers
Wednesday, 22 October, 2008


Privately held Sydney biotech Human Genetic Signatures has signed a licensing agreement with US diagnostics specialist ProGen Tech to develop assays for pathogens such as MRSA and Clostridium difficile.

The assays will be integrated into ProGen Tech’s Entura nucleic acid purification system.

Human Genetic Signatures’ technology is called 3base, which is designed to simplify the genomes of microbial targets to aid detection. The company has also developed a DNA methylation analysis methodology called MethylEasy.

ProGen Tech hopes to present manual assays to the US FDA next year, followed by a fully automated version in 2010.

The equipment is aimed at the molecular and clinical diagnostics markets.

Related Articles

New species of bacteria discovered in prostate cancer patients

Researchers have discovered the genetic blueprints of 18 new bacterial species in prostate cancer...

Award-winning system automates vial filling for cell therapy

Celleo's Larkem V40 — created to address one of the bottlenecks holding back cell...

Air pollutant exposure linked to glaucoma, cataracts and suicide

People who are exposed to high levels of air pollution are more likely to develop glaucoma and...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd